Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: URT014
MIFTS: 39

Ureterolithiasis

Categories: Nephrological diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Ureterolithiasis

About this section

MalaCards integrated aliases for Ureterolithiasis:

Name: Ureterolithiasis 12 45 15 17 74
Calculus of Ureter 12
Ureteric Calculus 12
Ureteral Calculi 74
Ureteric Stone 12

Classifications:

MalaCards categories:
Anatomical: Nephrological diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:14146
ICD9CM 36 592.1
MeSH 45 D053039
NCIt 51 C114696
SNOMED-CT 69 31054009 95573009
ICD10 34 N20.1
Sources

Summaries for Ureterolithiasis

About this section
MalaCards based summary : Ureterolithiasis, also known as calculus of ureter, is related to nephrolithiasis and nephrolithiasis, calcium oxalate. An important gene associated with Ureterolithiasis is APRT (Adenine Phosphoribosyltransferase), and among its related pathways/superpathways are Calcium signaling pathway and Salivary secretion. The drugs Tamsulosin and Alfuzosin have been mentioned in the context of this disorder. Affiliated tissues include kidney and adrenal gland, and related phenotypes are behavior/neurological and renal/urinary system

Wikipedia : 77 Kidney stone disease, also known as urolithiasis, is when a solid piece of material (kidney stone)... more...

Sources

Related Diseases for Ureterolithiasis

About this section

Diseases related to Ureterolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 50)
# Related Disease Score Top Affiliating Genes
1 nephrolithiasis 10.5
2 nephrolithiasis, calcium oxalate 10.3
3 appendicitis 10.2
4 urinary tract obstruction 10.2
5 horns in sheep 10.2
6 hydronephrosis 10.1
7 acute pyelonephritis 10.0
8 ureterocele 10.0
9 cystinuria 10.0
10 adenine phosphoribosyltransferase deficiency 10.0
11 atrial fibrillation 10.0
12 pyelonephritis 10.0
13 squamous cell papilloma 10.0
14 papilloma 10.0
15 endometriosis 10.0
16 anuria 10.0
17 ureteral obstruction 10.0
18 dihydroxyadeninuria 10.0
19 renal dysplasia 10.0
20 exstrophy of bladder 10.0
21 ureteral benign neoplasm 10.0
22 transitional cell carcinoma 10.0
23 angiomyolipoma 10.0
24 embryoma 10.0
25 priapism 10.0
26 meningitis 10.0
27 tuberculous meningitis 10.0
28 fibromuscular dysplasia 9.9
29 thrombocytopenic purpura, autoimmune 9.9
30 vesicoureteral reflux 1 9.9
31 brittle bone disorder 9.9
32 leptin deficiency or dysfunction 9.9
33 blood group, gerbich system 9.9
34 end stage renal failure 9.9
35 systemic mastocytosis 9.9
36 small cell carcinoma 9.9
37 thrombosis 9.9
38 azoospermia 9.9
39 cystitis 9.9
40 ankylosis 9.9
41 gastroenteritis 9.9
42 glandular cystitis 9.9
43 teratoma 9.9
44 purpura 9.9
45 mastocytosis 9.9
46 uremia 9.9
47 adenoma 9.9
48 nephrogenic adenoma 9.9
49 actinomycosis 9.9
50 col1a1/2-related osteogenesis imperfecta 9.9

Comorbidity relations with Ureterolithiasis via Phenotypic Disease Network (PDN): (show all 12)


Acute Cystitis Bladder Neck Obstruction
Hydronephrosis Nephrolithiasis, Uric Acid
Nephrolithiasis, X-Linked Recessive, with Renal Failure Paralytic Ileus
Prostate Cancer Prostatic Hypertrophy
Pyelonephritis Urethral Calculus
Urethral Stricture Urinary Tract Obstruction

Graphical network of the top 20 diseases related to Ureterolithiasis:



Diseases related to Ureterolithiasis
Sources

Symptoms & Phenotypes for Ureterolithiasis

About this section

MGI Mouse Phenotypes related to Ureterolithiasis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.35 ADRA1A AKAP5 APBB1 APRT CHRM3
2 renal/urinary system MP:0005367 8.92 ADRA1A APRT CHRM3 SLC12A3
Sources

Drugs & Therapeutics for Ureterolithiasis

About this section

Drugs for Ureterolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 95)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tamsulosin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 106133-20-4 129211
2
Alfuzosin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 81403-80-7 2092
3
Nefopam Approved, Investigational Phase 4 13669-70-0
4
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
5
Morphine Approved, Investigational Phase 4 57-27-2 5288826
6
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
7
Silodosin Approved Phase 4,Phase 3,Phase 2 160970-54-7
8
Diclofenac Approved, Vet_approved Phase 4,Not Applicable 15307-86-5 3033
9
Acetaminophen Approved Phase 4,Phase 3,Not Applicable 103-90-2 1983
10
Oxycodone Approved, Illicit, Investigational Phase 4,Not Applicable 76-42-6 5284603
11
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
12
Sodium Citrate Approved, Investigational Phase 4 68-04-2
13
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
14
Calcium Approved, Nutraceutical Phase 4,Phase 3 7440-70-2 271
15
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
16 Naftopidil Investigational Phase 4,Phase 3 57149-07-2
17 Adrenergic alpha-1 Receptor Antagonists Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
18 Adrenergic Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
19 Adrenergic alpha-Antagonists Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
20 Adrenergic Antagonists Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
21 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
22 Calcium, Dietary Phase 4,Phase 3
23 Platelet Aggregation Inhibitors Phase 4,Phase 3
24 calcium channel blockers Phase 4,Phase 3
25 Hormones Phase 4,Phase 3,Not Applicable
26 Antihypertensive Agents Phase 4,Phase 3
27 Peripheral Nervous System Agents Phase 4,Phase 3,Not Applicable
28 Central Nervous System Depressants Phase 4,Not Applicable
29 Anti-Inflammatory Agents Phase 4,Not Applicable
30 Cyclooxygenase Inhibitors Phase 4,Not Applicable
31 Antirheumatic Agents Phase 4,Not Applicable
32 Analgesics, Opioid Phase 4,Not Applicable
33 Analgesics Phase 4,Phase 3,Not Applicable
34 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Not Applicable
35 Ketorolac Tromethamine Phase 4
36 Analgesics, Non-Narcotic Phase 4,Not Applicable
37 Narcotics Phase 4,Not Applicable
38 Vasodilator Agents Phase 4,Phase 3
39 Antipyretics Phase 4,Not Applicable
40 Pharmaceutical Solutions Phase 4,Not Applicable
41 Antibiotics, Antitubercular Phase 4,Not Applicable
42 Anti-Bacterial Agents Phase 4,Not Applicable
43 Anti-Infective Agents Phase 4,Not Applicable
44 Cytochrome P-450 Enzyme Inhibitors Phase 4
45 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
46 Topoisomerase Inhibitors Phase 4
47 Cyclooxygenase 2 Inhibitors Phase 4,Not Applicable
48 Phosphodiesterase 5 Inhibitors Phase 4
49 Sildenafil Citrate Phase 4 171599-83-0
50 Citrate Phase 4

Interventional clinical trials:

(show top 50) (show all 84)
# Name Status NCT ID Phase Drugs
1 Treatment of Upper Ureteric Stones Unknown status NCT02469766 Phase 4
2 The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study Unknown status NCT00489112 Phase 4 Alfuzocine XL 10 mg once a day
3 Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones Unknown status NCT01167062 Phase 4 Tamsulosin Hydrochloride OCAS 0.4 mg
4 The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones Unknown status NCT00451061 Phase 4 Alfuzosin;Tamsulosin
5 Naftopidil 75mg for Improving Clearance of Urinary Stones Unknown status NCT02011737 Phase 4 naftopidil 75mg
6 Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic Unknown status NCT01543165 Phase 4 Ketorolac and nefopam balanced analgesia;Balanced analgesia using ketorolac and morphine;Pain control with single analgesics (ketorolac)
7 Nefopam and Morphine Consumption in the Treatment of Ureteral Calculi Completed NCT00639574 Phase 4 Néfopam
8 Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones Completed NCT01533389 Phase 4 Silodosin;Placebo
9 Tamsulosin for Urolithiasis in the Emergency Dept Completed NCT00382265 Phase 4 tamsulosin
10 Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management Completed NCT02187614 Phase 4 Diclofenac;Morphine;Paracetamol;Placebos
11 Antibiotic Prophylaxis Before Shock Wave Lithotripsy Recruiting NCT03692715 Phase 4 Ciprofloxacin;Placebo
12 Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy Recruiting NCT03614052 Phase 4 Tamsulosin Hydrochloride 0.4 milligrams;Placebo Oral Tablet
13 Study of Ketorolac Versus Opioid for Pain After Endoscopy Recruiting NCT03888144 Phase 4 Oxycodone;Ketorolac
14 Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones Active, not recruiting NCT02519153 Phase 4 Sildenafil
15 Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment Enrolling by invitation NCT03229889 Phase 4 Cialis 5Mg Tablet;Flomax 0.4Mg Capsule;Placebo
16 Silodosin Versus Tamsulosin for Treatment of Ureteral Stones Terminated NCT02369744 Phase 4 Silodosin;Tamsulosin
17 Celecoxib (Celebrex) in the Management of Acute Renal Colic Withdrawn NCT00304317 Phase 4 celecoxib
18 Alfuzosin for Medical Expulsion Therapy of Ureteral Stones Unknown status NCT00713739 Phase 3 Alfuzosin;nifedipine;doxazosin;prazosin
19 Evaluation of Tamsulosin in the Treatment of Ureteral Stones Completed NCT00151567 Phase 3 Tamsulosin;Placebo
20 Medical Expulsive Therapy for Ureter Stone Using Naftopidil Completed NCT01952314 Phase 3 Naftopidil 75mg;Placebo for Naftopidil;Standard treatment
21 Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi Completed NCT00177086 Phase 3
22 Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm. Terminated NCT02090439 Phase 3 Silodosin
23 Use of Alfuzosin in Stone Treatment With ESWL Withdrawn NCT00388271 Phase 3 Alfuzosin (Xatral);standard treatment
24 Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin Unknown status NCT00478998 Phase 2 Tamsulosin
25 Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy Unknown status NCT00409227 Phase 2 Alpha blocker-alfuzosin;placebo
26 Study of Silodosin to Facilitate Passage of Urinary Stones Completed NCT01144949 Phase 2 silodosin;placebo
27 A Dose-finding Study of Silodosin in Patients With Urinary Calculi Completed NCT01539265 Phase 2 silodosin;silodosin;placebo
28 Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain Recruiting NCT02744430 Phase 2 Mirabegron
29 Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy Completed NCT02032316 Phase 1
30 Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy Unknown status NCT01884870 Not Applicable
31 US-Non Contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up Unknown status NCT02539004
32 Comparative Treatment Study in Patients With Lower Ureteral Stones Unknown status NCT00397397
33 Impact of Low Dose Fluoroscopy in Ureteroscopy Unknown status NCT02704949 Not Applicable
34 Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia. Unknown status NCT01008267
35 Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy Unknown status NCT02279927 Not Applicable
36 Intraureteral Lidocaine for Post-Ureteroscopy Pain Unknown status NCT01450566 Not Applicable Lidocaine;Saline
37 Delayed or Direct Ureteroscopy in the Treatment of Pediatric Calcular Anuria Unknown status NCT02139059 Not Applicable
38 ESWL vs URS in Management of Upper Third Ureteric Calculi Completed NCT03559738
39 Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone Completed NCT03726502 Not Applicable
40 The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients Completed NCT00600405 Not Applicable tamsulosin;Standard therapy with ibuprofen and oxycodone.
41 Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter' Completed NCT00517205
42 Medical Expulsive Therapy of Single Distal Ureteral Stones Completed NCT00831701 Not Applicable Tamsulosin;Placebo
43 The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients Completed NCT00448123 Not Applicable Tamsulosin;Placebo
44 Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach Completed NCT01792765 Not Applicable
45 Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis Completed NCT00762424 Not Applicable Flowmax;placebo
46 Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones? Completed NCT02635490
47 Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis Completed NCT01637519
48 Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage Completed NCT02055430 Not Applicable
49 Role of Flexible Cystoscopy in Laparoscopic Stone Surgery Completed NCT01277198
50 The Usefulness of Flexible Cystoscopy for Preventing Double-J Stent Malposition After Laparoscopic Ureterolithotomy Completed NCT03150446 Not Applicable

Search NIH Clinical Center for Ureterolithiasis

Cochrane evidence based reviews: ureterolithiasis

Sources

Genetic Tests for Ureterolithiasis

About this section
Sources

Anatomical Context for Ureterolithiasis

About this section

MalaCards organs/tissues related to Ureterolithiasis:

42
Kidney, Adrenal Gland
Sources

Publications for Ureterolithiasis

About this section

Articles related to Ureterolithiasis:

(show top 50) (show all 101)
# Title Authors Year
1
Re: Minimizing the Cost of Treating Asymptomatic Ureterolithiasis. ( 30577359 )
2019
2
Acute synchronous appendicitis and obstructing ureterolithiasis. ( 30108673 )
2018
3
Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat. ( 30568915 )
2018
4
Bilateral ureterolithiasis: A true positive and false negative PoCUS exam in a patient with renal colic. ( 29606152 )
2018
5
Perinephric Fat Stranding Is Associated with Elevated Creatinine Among Patients with Acutely Obstructing Ureterolithiasis. ( 29943669 )
2018
6
CONTACT ULTRASOUND LITHOTRIPSY DURING URETEROLITHIASIS THERAPY. AN ANALYSIS OF LATE POSTOPERATIVE COMPLICATIONS. ( 30358535 )
2018
7
Narcotic Pain Control for Ureterolithiasis Is Associated With Unnecessary Repeat Imaging in the Emergency Department. ( 30358635 )
2018
8
Epidemiological and imaging features that can affect the detection of ureterolithiasis on ultrasound. ( 30369654 )
2018
9
Ureterolithiasis and the quest for rational use of diagnostic imaging methods. ( 30559568 )
2018
10
Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. ( 27506951 )
2017
11
Comparison of prone vs. supine unenhanced CT imaging in patients with clinically suspected ureterolithiasis. ( 27670877 )
2017
12
Spontaneous proximal ureteric rupture secondary to ureterolithiasis. ( 28069871 )
2017
13
Ureterolithiasis: Management in an environment with limited facilities. ( 28513524 )
2017
14
Comparison between double-pigtail ureteral stents and ureteral bypass devices for treatment of ureterolithiasis in cats. ( 28763282 )
2017
15
Is Hydronephrosis on Ultrasound Predictive of Ureterolithiasis in Patients with Renal Colic? ( 27154825 )
2016
16
Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic. ( 27314408 )
2016
17
Beyond ureterolithiasis: gamut of abnormalities affecting the ureter. ( 27317212 )
2016
18
Management of Ureterolithiasis in a Patient with Crossed Unfused Renal Ectopia. ( 27403369 )
2016
19
Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic Review. ( 25917723 )
2015
20
The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis. ( 26717117 )
2015
21
Indwelling double pigtail ureteral stent combined or not with surgery for feline ureterolithiasis: complications and outcome in 15 cases. ( 24305471 )
2014
22
Tamsulosin for treatment of unilateral distal ureterolithiasis: a systematic review and meta-analysis. ( 24852587 )
2014
23
Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults. ( 23180444 )
2013
24
Re: terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. ( 23421365 )
2013
25
Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. ( 23503876 )
2013
26
Pyeloduodenal fistula due to proximal ureterolithiasis and its successful conservative management. ( 24051966 )
2013
27
Synchronous obstructive ureterolithiasis and acute appendicitis. ( 24960802 )
2012
28
Bedside renal ultrasound in the evaluation of suspected ureterolithiasis. ( 21185667 )
2012
29
Unusual presentation of bilateral ureteroceles with ureterolithiasis in a patient after robotic prostatectomy. ( 22546412 )
2012
30
Bladder bulge: unifying old and new sonographic bladder wall abnormalities in ureterolithiasis. ( 23358632 )
2012
31
Endoscopic holmium laser treatment for ureterolithiasis. ( 24578918 )
2012
32
Health related quality of life in ureteral stone patients: post-ureterolithiasis. ( 21461963 )
2011
33
Ureterolithiasis in children. ( 21585171 )
2011
34
The effect of alpha-blockade in emergency department patients with ureterolithiasis. ( 19217243 )
2010
35
The sensitivity of transabdominal ultrasound in the diagnosis of ureterolithiasis. ( 21203595 )
2010
36
A case of calcified ureteritis cystica: an indiscernible condition from ureterolithiasis. ( 19655701 )
2009
37
Acute onset of renal colic from bilateral ureterolithiasis: a case report. ( 19829794 )
2009
38
Conventional and reduced radiation dose of 16-MDCT for detection of nephrolithiasis and ureterolithiasis. ( 18094305 )
2008
39
The utility of unenhanced helical CT in assessing the frequency of ureterolithiasis in Saudi patients. ( 18246228 )
2008
40
Cost-effectiveness analysis (CEA) of intravenous urography (IVU) and unenhanced multidetector computed tomography (MDCT) for initial investigation of suspected acute ureterolithiasis. ( 18300151 )
2008
41
Usefulness of urinalysis in following patients with distal ureterolithiasis. ( 18578655 )
2008
42
Type IV ureteral triplication associated with ipsilateral ureterocele with ureterolithiasis and contralateral duplication with an ectopic ureteral orifice. ( 19138195 )
2008
43
Comparison between ultrasound and noncontrast helical computed tomography for identification of acute ureterolithiasis in a teaching hospital setting. ( 17625708 )
2007
44
Ureteroscopical treatment of ureterolithiasis in childhood. Our experience. ( 16752883 )
2006
45
Electro-acupuncture treatment for the upper segment ureterolithiasis under B-ultrasonography. ( 15889513 )
2005
46
Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. ( 16230122 )
2005
47
Unenhanced helical CT of ureterolithiasis: incidence of secondary urinary tract findings. ( 15058632 )
2004
48
Ureterolithiasis after Cohen re-implantation--case report. ( 15070415 )
2004
49
Diagnostic value of attenuation measurements of the kidney on unenhanced helical CT of obstructive ureterolithiasis. ( 15100127 )
2004
50
Unenhanced helical CT scan for ureterolithiasis. ( 15321049 )
2004
Sources

Variations for Ureterolithiasis

About this section
Sources

Expression for Ureterolithiasis

About this section
Search GEO for disease gene expression data for Ureterolithiasis.
Sources

Pathways for Ureterolithiasis

About this section

Pathways related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Calcium signaling pathway 38
Show member pathways
 11.44 ADRA1A CHRM3
2
Salivary secretion 38
Show member pathways
 11.17 ADRA1A CHRM3
3
Monoamine GPCRs 1
Show member pathways
 10.66 ADRA1A CHRM3
Sources

GO Terms for Ureterolithiasis

About this section

Cellular components related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 dendritic spine GO:0043197 8.96 AKAP5 APBB1
2 integral component of presynaptic membrane GO:0099056 8.62 ADRA1A CHRM3

Biological processes related to Ureterolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signal transduction GO:0007165 9.56 ADRA1A AKAP5 APBB1 CHRM3
2 regulation of vasoconstriction GO:0019229 9.16 ADRA1A CHRM3
3 positive regulation of smooth muscle contraction GO:0045987 8.96 ADRA1A CHRM3
4 smooth muscle contraction GO:0006939 8.62 ADRA1A CHRM3
Sources

Sources for Ureterolithiasis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....